Summer 2018 | Live Blog | Product Theater | More Than Skin Deep with Cosentyx (secukinumab): Proven Effective for Psoriatic Arthritis

Andrea Nguyen, MS, PA-C presented the second product theater on the first day of the SDPA Annual Summer Conference. She discussed Cosentyx, the first and only fully human Il-17A antagonist approved for the treatment of psoriatic arthritis and moderate to severe plaque psoriasis. Cosentyx is also indicated for the treatment of ankylosing spondylitis. Ms. Nguyen …